Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoverageVideo

VIDEO: Expert discusses H. pylori-associated gastric cancer mechanisms, research

January 22, 2016
SAN FRANCISCO — Keith T. Wilson, MD, from Vanderbilt University Medical Center, discusses his keynote lecture on Helicobacter
Meeting News CoveragePerspective

CarPac pre-op chemoradiation benefits patients with resectable esophageal cancer

January 22, 2016
SAN FRANCISCO — After induction therapy, patients with resectable esophageal adenocarcinoma achieved superior pathological complete response…
Meeting News CoveragePerspective

Advanced gastric cancer patients may have better overall survival with mFOLFOX7 followed by mFOLFIRI

January 21, 2016
SAN FRANCISCO — First-line treatment with modified FOLFOX7 or modified FOLFIRI chemotherapy resulted in comparable progression-free survival…
Meeting News CoverageVideo

VIDEO: BE screening only feasible in high-risk patients until better techniques become available

January 21, 2016
SAN FRANCISCO — Gary W. Falk, MD, from the University of Pennsylvania Perelman School of Medicine and the Abramson Cancer Center, discusses…
Meeting News Coverage

Everolimus delays progression of neuroendocrine tumors

January 20, 2016
Everolimus appeared to delay the progression of neuroendocrine tumors that originate in the gastrointestinal tract or are of unknown origin…
Meeting News CoveragePerspective

Short-course chemoradiation regimen effective, less toxic for advanced rectal cancer

January 19, 2016
A short-course 5-day radiation regimen followed by consolidated chemotherapy prior to surgery appeared as effective as and less toxic than the…
Meeting News CoveragePerspective

Lutathera improves outcomes in metastatic midgut neuroendocrine tumors

January 19, 2016
Treatment with 177Lutetium-DOTATE appeared to improve the overall response rate and prolonged PFS compared with octreotide among previously treated…
Meeting News Coverage

Less-intensive regimen maintained efficacy, reduced toxicity in metastatic pancreatic cancer

February 3, 2015
A less-intensive first-line treatment regimen for patients with metastatic pancreatic cancer may decrease toxicity and reduce costs while maintaining…
Meeting News Coverage

Panitumumab plus FOLFOX6 benefited patients with RAS wild-type metastatic colorectal cancer

February 2, 2015
Patients with RAS wild-type metastatic colorectal cancer treated with panitumumab plus modified FOLFOX6 chemotherapy experienced faster and more…
Meeting News Coverage

Lanreotide shows promise in patients with pancreatic neuroendocrine tumors

January 28, 2015
Lanreotide demonstrated antitumor activity with a manageable safety profile in patients with pancreatic neuroendocrine tumors, according to a…